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Bacterial superantigens (SAgs) are enterotoxins that bind to MHC-II and TCR molecules,
activating as much as 20% of the T cell population and promoting a cytokine storm which
enhances susceptibility to endotoxic shock, causing immunosuppression, and hindering
the immune response against bacterial infection. Since monocytes/macrophages are
one of the first cells SAgs find in infected host and considering the effect these
cells have on directing the immune response, here, we investigated the effect of four
non-classical SAgs of the staphylococcal egc operon, namely, SEG, SEI, SEO, and
SEM on monocytic–macrophagic cells, in the absence of T cells. We also analyzed
the molecular targets on APCs which could mediate SAg effects. We found that egc
SAgs depleted the pool of innate immune effector cells and induced an inefficient
activation of monocytic–macrophagic cells, driving the immune response to an impaired
proinflammatory profile, which could be mediated directly or indirectly by interactions
with MHC class II. In addition, performing surface plasmon resonance assays, we
demonstrated that non-classical SAgs bind the gp130 molecule, which is also present
in the monocytic cell surface, among other cells.
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INTRODUCTION
Staphylococcus aureus is one of the major pathogens responsible for human and veterinarian
diseases and life-threatening infections ranging from skin and soft tissues to toxic shock syndrome
(TSS) and sepsis (1–4). The last two conditions are characterized by a non-controlled release of
proinflammatory cytokines which can lead to multiple organ failure and death (5).
Many virulence factors of S. aureus have been described; among them, staphylococcal
enterotoxins (SEs) or superantigens (SAgs) are some of the most important. These toxins
can promote immunosuppression in the infected host, allowing bacterial spread and further
sepsis (6–8). SAgs are not circumscribed only to S. aureus; other important pathogens such us
Streptococcus pyogenes produce a broad repertoire of toxins with SAg activity. Staphylococcal and
streptococcal SAgs share a common tridimensional structure and display high similarity in their
amino acid sequences (9).
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SAgs interact simultaneously with major histocompatibility
complex class II molecules (MHC-II) on antigen-presenting cells
(APC) and with the T cell receptors (TCR) on the surface of
T cells, in a non-conventional way as unprocessed molecules.
Due to these interactions, a cytokine storm is released, leading
to TSS and host immunosuppression (10–15). In addition,
SAgs are strongly associated with autoimmune diseases and
food poisoning (16–21). Since SAgs are resistant to high
temperature and enzymatic treatment and can act at very low
concentrations, they were classified as category B priority agents
by the CDC because of their potential use in bioterrorism and
biological warfare.
Staphylococcal SAgs are described as classical (SEA to SEE
and TSST-1) and non-classical enterotoxins (SEG to SEU) (22–
25). This division between classical and non-classical SAgs is
also extended to the streptococcal pyrogenic exotoxins (SPE
A–C, F–H, and J and streptococcal superantigen A) and the
streptococcal mitogenic exotoxin Z (SMEZ). The interaction
between immunological molecular targets and classical SAgs is
very well-documented (26–33). The crystallographic structures
of classical SAgs in complex with the TCR and the MHC-II
molecules allowed the identification of a conserved motif over
the SAgs surfaces involved in the interaction. Less is known about
the interaction between these receptors on the T cells or the APCs
and non-classical SAgs. The crystallographic structures available,
would suggest new residues over the SAg surface involved in the
interaction with TCR and MHC-II molecules (34–39).
In addition, biological differences had been reported between
classical and non-classical SAgs. In this regard, an important
aspect is the higher stimulatory capacity that SEB and SMEZ,
both classical SAgs that bind CD28 (40–44), possess over the
non-classical SAgs, for which interaction with CD28 has not
been studied yet. These classical SAgs, which also interact with
B7.2 (42, 43) display a stimulatory capacity three orders higher
compared with SEG and SEI (27, 45, 46).
The interaction between the co-receptors CD28 and B7.2 and
classical SAgs as SEB, SPEA, SMEZ, and SEA has been deeply
studied (40–44, 47). A conserved motif among SAgs, located at
beta strand 8-alpha helix 4, distant from the TCR and MCH-II
binding site, would constitute the binding region with these new
ligands. The interaction with these co-receptors could allow a full
T cell activation.
The glycoprotein 130 (gp130), a signal transductor of IL-6,
was also described as a new classical SAg target. Only one study
reported that the staphylococcal SAg SEA could bind to gp130
on the adipocytes’ surface (48). There are no other publications
describing this interaction and its biological significance on cells
of the immune system.
SAgs, such as other virulence factors, are encoded in
mobile genetic elements located in pathogenicity islands, phages,
plasmids, and transposons. The genes of non-classical SAgs, SEG,
SEI, SEM, SEN, and SEO belong to the enterotoxin gene cluster,
egc, which is located in pathogenicity island 3 (18). At present,
seven forms of the egc operon were described (49). Sometimes,
strains carrying the egc operon are also bearers of the seu gene,
increasing the virulence of the strain (18, 49); seu is harbored
in the operon instead of the pseudogenes ent1 and ent2, which
are present in most forms of the operon. The egc SAgs genes are
described as the most prevalent SAgs genes (50–55).
The interaction between SAgs and TCR is very well-
characterized (29, 31, 38). Less is known about the outcome of
SAg interaction with innate immune cells. Some studies have
analyzed the interaction of bacterial SAgs with humanmonocytes
enriched from peripheral blood (56), dendritic cells (DCs) (57–
59), and murine neutrophils (60). Since monocytes/macrophages
are one of the first cells SAgs found in infected hosts and
considering the effect these cells have on directing the immune
response, here we investigated the effect of four SAgs of
the staphylococcal egc operon: SEG, SEI, SEO, and SEM
on monocytic–macrophagic cells, in the absence of T cells,
employing THP-1 cells, a human cell line which is broadly used
as a model of monocytes and macrophages (61–63). We also
analyzed other molecular targets on APCs which could directly
or indirectly mediate egc SAgs effects. We found that egc SAgs
depleted the pool of innate immune effector cells and induced
an inefficient activation of monocytic–macrophagic cells, driving
the immune response to an impaired proinflammatory profile,
which could be mediated directly or indirectly by interactions
with MHC class II. In addition, performing surface plasmon
resonance (SPR), we demonstrated that non-classical egc SAgs
bind to the gp130 molecule, which is ubiquitously expressed in
immune cells.
MATERIALS AND METHODS
Evaluation of SAg Genes in Autochthonous
Strains of S. aureus
S. aureus strains were isolated from patients and characterized in
theHospital General de Agudos “J.M. RamosMejía.” The isolates
were microbiologically identified as S. aureus due to their ability
to coagulate citrated rabbit plasma (positive coagulase) and to
produce clumping factor. Additionally, routine antibiograms
were performed. The strains were isolated in LB-agar and
cultured in antibiotic-free Trypticase soy broth medium with 3%
N-Z amine and 1% yeast extract (64) at 37◦C with moderate
agitation (200 rpm) up to DO600nm = 1.
DNA was isolated using the Miniprep genomic DNA isolation
kit (QIAGEN, GmbH-Germany), and its integrity was checked in
0.8% agarose gel. SAg genes in the clinical isolates were evaluated
by polymerase chain reaction (PCR) (45, 65–67) using specific
primers for sags. Fc30 (35) and hsp60 were used as a positive
control (SP Table 1). Positive cases were repeated and amplified
using a high-fidelity polymerase (Invitrogen, Thermo Fisher
Scientific Inc.). The sequencing was developed by Macrogen
Inc. (Korea).
Sequence Analysis
Nucleotide and amino acid sequences were analyzed using
the ExPASy Protein Translate program (Swiss Institute of
Bioinformatics). Alignments were performed with BLAST-
NCBI and ClustalW. Three subclones were analyzed to ensure
that no Taq Platinum Plus (Promega)-related mutations were
introduced. For construction and analysis of sequence similarities
and secondary structure, ESPript software was used as described
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elsewhere (68). The sequences were deposited at the NCBI
Protein Data Bank and published with the accession numbers
MK947360, MK947361, MK947362, MK947363, MK947364,
MK947365, and MK947366.
Monospecific Mouse anti-SAg Sera
Animals were manipulated following the ethical standards of
the Universidad de Buenos Aires, Facultad de Farmacia y
Bioquímica, where the work was carried out (Resolution No.
2349/18). Polyclonal antisera were obtained by immunization
of Balb/c mice with 1 mg/ml of recombinant SEG, SEI, or SSA
mixed with Freund’s adjuvant. Boosts were administered on days
7, 14, and 28. Sera obtained on day 35 were diluted 10-fold and
tested by ELISA and immunoblotting. Antisera were enriched
in the immunoglobulin fraction by saline precipitation followed
by molecular exclusion purification. The enriched fraction was
treated with pepsin and then the purified F(ab)’2 fragment
was used in the following assays to avoid cell proliferation or
activation due to the interaction of mouse Fc fragments with
human Fc receptors.
Reagents and Bacterial Strains
All chemical reagents were of analytical grade and purchased
from Sigma (St. Louis, MO). Restriction enzymes, Taq DNA
polymerase, T4 ligase, and buffers for cloning were purchased
from New England Biolabs, Inc. (Beverly, MA). Ultrapure
agarose was purchased from GIBCO BRL-Life Technologies
(Rockville, MD). Recombinant Human Glycoprotein 130 Fc
Chimera (gp130) was purchased from R&D (671-GP, Bio-techne,
Minneapolis, MN).
Biacore chips and the amino coupling kit were purchased
from General Electric Healthcare Life Science (Piscataway, NJ).
Escherichia coli DH5α and BL21 (DE3) strains were from
Stratagene (La Jolla, CA, USA).
Recombinant Expression and Purification
of Superantigens
Streptococcal SSA and staphylococcal SEI and SEG were
produced and purified as previously described (35, 65). Briefly,
proteins cloned in pET-26b were expressed in E. coli BL21 and
purified by Ni-NTA affinity chromatography, followed by S-
200 molecular exclusion. Proteins were treated with agarose-
polymyxin B (Sigma Aldrich, St. Louis, MO) to remove LPS
traces. SEM and SEO were cloned and produced following the
same strategy described earlier using strain 41,399.
HLA-DR1 Expression and Purification
HLA-DR1 was produced by in vitro folding from bacterial
inclusion bodies as described elsewhere (69). Briefly, plasmids
encoding the HLA-DR1 α chain (DRA∗0101) and β chain
(DRB1∗0101) were transformed separately into E. coli BL21
(DE3) cells (Stratagene). Bacteria were grown at 37◦C to
an absorbance of 0.6–0.7 at 600 nm, and then 1mM IPTG
was added. Inclusion bodies were extensively washed and the
subunits purified under denaturing and reducing conditions
using an HQ50 anion exchange column (PerSeptive Biosystems).
Yields of DR1 α and β subunits were 16 and 20mg per liter
of culture medium, respectively. Purified subunits were diluted
dropwise with constant stirring to a final concentration of
50µg/ml into a folding solution of 20mM Tris-HCl (pH 8.5),
25% (w/v) glycerol, 0.5mM EDTA, 3mM reduced glutathione,
and 0.3mMoxidized glutathione and kept at 4◦C for 2 days in the
presence of 1µM HA 306–318 peptide (PKYVKQNTLKLAT).
Recombinant HA/HLA-DR1 was purified from the folding
mixture using a Mono Q anion exchange column (Amersham
Biosciences) equilibrated with 20mM Tris-HCl (pH 8.0) and
developed with a linear NaCl gradient. The protein eluted as a
single peak at 0.15 M NaCl.
Purity of Recombinant Proteins and LPS
Determination
For every recombinant protein used in this work, purity was
evaluated by SDS-Page (egc SAgs in SP Figure 1). In addition,
the amount of remaining endotoxin was evaluated by the
Pierce LAL chromogenic endotoxin quantitation Kit (Thermo
Scientific) following the manufacturers’ instructions. For all
recombinant proteins, it was verified that <0.1 EU/ml of
endotoxin was present.
Cell Culture
The human monocytic leukemia cell line THP-1 was obtained
from the American Type Culture Collection (Manassas, VA)
and cultured in complete medium [RPMI-1640 (Thermo Fisher
Scientific), supplemented with 10% fetal bovine serum (FBS)
(Internegocios S.A., B.A., Argentina), 2 mM glutamine, 1 mM
pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin].
When appropriate, and before each assay, cells (7.5× 105 to 10
× 105 cells/ml) were treated for 72 h with phorbol 12-myristate
13-acetate (PMA, Sigma Aldrich, Saint Louis, MO) (40 ng/ml) or
left untreated. Before each assay, cells were counted after trypan
blue staining in a Neubauer chamber; only samples with cell
viability over 98% were used.
Cell Proliferation Assays
Cell inhibition assays were assessed in THP-1 cells, cultured in the
presence of SAgs (from 0.001 to 10µg/ml) or medium (control)
for 24–72 h. For 48 h of treatment, cells were incubated for 30 h
at 37◦C in 5% (v/v) CO2. After that, 1 mCi of [3H] thymidine
per well was added, and cells were incubated for additional 18 h
and then harvested on glass fiber filters. The incorporation of
radioactivity was measured using a liquid scintillation analyzer
Tri-Carb 2810 TR (Perkin Elmer). To evaluate the specificity of
our results and putative targets involved, inhibition assays were
repeated with the same concentrations of SAgs, pre-incubated
or not with specific F(ab)’2 fragments (10µg/ml) and DR1
recombinant protein in equimolar concentration with the toxins
assayed for 1 h at 37◦C, and then incubated with cells for 48 h at
0.1× 106 cell/well.
Immunofluorescence Assays
THP-1 cells (5 × 105 cells/well) were incubated for 48 h with
10µg/ml of each SAg or left untreated (control 1). Cells
were fixed with PFA 2% (12min at room temperature) and
washed with PBS, and then the pellet was incubated for 30min
with 0.25% Triton X-100 for permeabilization. Blocking was
performed by incubating 20min at RT with 10% BSA-PBS.
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Primary antibodies, mouse sera anti Sags, or normal mouse
sera (control 2) (dilution 1/300) were incubated for 1.5 h, then
washed, and incubated with goat anti-mouse IgG conjugated
with Alexa-488 (Biolegend) (dilution 1/1,000) for 1 h at RT.
After final washes, the pellet was resuspended in DAPI (Sigma,
St Louis, MO) (1µg/ml) for 30min. Samples were centrifuged,
and a drop was observed under a fluorescent microscope
(Olympus BX51TRF).
Cell Death Assays
Cell viability was measured using the fluorescein diacetate (FDA)
and propidium iodide (PI) assay, both purchased from Sigma
(St. Louis, MO). FDA stain was used as a control of viability.
Control and SAg-treated (10µg/ml) cells were collected and
washed twice in PBS before re-suspension in 1.4µM of FDA
and then in 1µg/ml of PI. The percentage of dead cells up-
taking PI was measured by flow cytometry (Partec, Germany)
and analyzed using Flowing Software (Cell Imaging Core, Turku
Centre for Biotechnology).
Evaluation of Apoptosis by Annexin V
For assessment of apoptotic death, the PE-Annexin V Apoptosis
Detection Kit I (BD Biosciences) was employed. Briefly, 5 ×
105 THP-1 cells were seeded in a 24-flat bottom plate and
incubated with SAgs (10µg/ml) or medium as a control for
48 h. Afterwards, cells were washed and resuspended in staining
buffer. After 15min of incubation with Annexin V-PE and 7-
AAD, samples were injected into the flow cytometer, and results
were analyzed using Flowing Software.
Dual Acridine Orange/Ethidium Bromide
Fluorescent Staining
To confirm the cell death rates using the PE-Annexin V
Apoptosis Detection Kit I, we assessed the dual acridine
orange/ethidium bromide (AO/EB) fluorescent staining,
visualized under a fluorescent microscope (Olympus BX51TRF).
THP-1 cells were treated with SAgs (10µg/ml) for 48 h. The
pelleted cell suspension (250 µl) was stained with 10 µl of
the dye mixture [10µM acridine orange and 10µM ethidium
bromide (Sigma)], which was prepared in PBS. Cells cultured
with medium were used as a control. For THP-1/PMA-treated
cells, the samples were evaluated attached to the cover glasses
at the same time that the supernatants were evaluated. The
morphology of 200 cells per sample was examined by fluorescent
microscopy within 20 min.
LDH Assay
Supernatants of THP-1 cells treated with SAgs for 48 h or
left untreated were evaluated using the optimized UV method
(DGKC) for lactate dehydrogenase (LDH): LDH-P (Wiener
Lab.). Samples were evaluated at 340 nm and 37◦C according to
the manufacturer’s indications.
Cytokine Determinations
Cytokines (CKs) IL-6, IL-12, IFN-È, TNF-α, IL-17A, and IL-10
were measured by ELISA from the supernatants (SN) of THP-
1 cells incubated with different concentrations of SAgs (R&D
Systems, Oxon, UK). Each experiment was repeated at least
three times.
Phenotypic Assay
THP-1 cells (106/ml) were incubated with 1µg/ml of SEG, SEI,
or SSA for 24 h at 37◦C in complete medium. CD14, CD40, and
CD86 expression was evaluated by flow cytometry (FACS) and
compared to basal expression in THP-1 cells incubated without
SAgs (control). Briefly, we analyzed the THP-1 phenotype
using FITC-labeled mAbs to CD40 and CD86 and PE-labeled
antibodies to CD14 (eBioscience). Stained cells were analyzed by
flow cytometry. At least 20,000 events were acquired for each
sample, and data analysis was performed using the WinMDI
software program. Results were expressed as percentage of
positive cells.
Phagocytosis Assays
THP-1 cells (106/ml) were cultivated with 108 UFC/ml of heat-
dead S. aureus labeled with FITC in the presence of different SAgs
(1µg/ml) or alone. All the assays were done in completemedium.
After 1–3 h at 37◦C, CO2 5% incubation, cells were washed and
resuspended in PBS-Trypan Blue to analyze the phagocytosis
of FITC-bacteria by flow cytometry. Results were expressed as
percentage of positive cells.
Surface Plasmon Resonance Assay
SPR analysis was performed using a BIAcore T100 instrument
(GEHealthcare). Gp130 protein was immobilized (2200 RU) on a
CM5 chip (GE Healthcare) surface by amine coupling according
to the manufacturer’s instructions. Soluble SEG, SEI, SEM, and
SEO were diluted in PBS, pH 7.4, with or without EDTA running
buffer, and injected over chip surfaces at a flow rate of 30 µl
min−1 for 60 s at 25 ◦C. Data were analyzed with the BIA
evaluation software (GE Healthcare).
Statistical Analysis
Results were tested statistically using one-way and two-way
ANOVA and Dunnett’s, Bonferroni’s, or Tukey’s multiple
comparison tests where appropriate, using commercially
available software (Graph-Pad Prism, GraphPad Software, San
Diego, CA, USA). Results were determined to be statistically
significant when a p < 0.05 was obtained. Images were edited
using Adobe Photoshop CC software (Adobe, CA, USA).
RESULTS
SAgs of the egc Operon Are the Most
Prevalent SAg Genes in the Evaluated
Strains
To evaluate the prevalence of classical and non-classical
staphylococcal sags in S. aureus isolated from adult patients of
our community, we analyzed 13 strains from ambulatory patients
who attended the emergency service of a public hospital in
Buenos Aires (SP Table 2). All strains were microbiologically
confirmed as S. aureus by coagulase reaction and production of
clumping factor.
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We assessed the presence of 15 different sags in the bacterial
genomic DNA by PCR (Table 1). Classical sags were found in
60% of the isolates, with sec3 showing the highest frequency. All
strains were negative for sea and see. Within the non-classical sag
genes, ser and sehwere not detected in any of the analyzed strains
when genomic DNA was evaluated.
The presence of the egc operon was detected in 54% of the
strains. sen [previously named as sek (54)] a gene that can
or cannot be present in the egc operon, showed the highest
prevalence (92%), followed by seu (62%). A non-significant
relationship was found between the severity of the infection or
the strain antibiotic resistance and the presence of sags.
These results are in concordance with several reports that
claimed that 80% of all S. aureus strains hold, on average, five or
six SAg genes, among which the egc SAgs are the most prevalent
today (50–55).
The egc operon was described for the first time by Jarraud
et al. (54). At that time, three forms of the egc operon were
described: egc1 (harboring seg, sei, sem, sen, seo, and ent1 and
ent2), egc2 (harboring seu instead of ent1 and ent2), and egc3
(containing sei, seu, sen and seg variants). Blaiotta et al. (70)
described egc forms 1–7 based on the length of the egc DNA
fragment and its restriction enzyme assay patterns. Here, we
described a non-reported form of the egc operon lacking the seo
gene, which we denominated egc8, in accordance with previous
works. Additionally, we found that sen was observed no matter
if any form of the cluster was present or not (92% prevalence
compared with 54% prevalence of the egc operon). Furthermore,
we found the presence of a reported variant of sei, sei2 (49, 52).
seg was found in seven isolated strains displaying slight
DNA variability with mutations in residues 6, 17, 30, and
77 (Figure 1A) when compared with the consensus sequence
(18, 64, 71). These mutations allowed us to group them as
A, which includes isolated strains 40,900, 41,026, 41,226, and
41,399 (accession numbers MK947360, MK947361, MK947362,
and MK947364) and B, which includes strains 41,395, 41,668,
and 41,674 (accession numbers MK947363, MK947365, and
MK947366) (Figure 1A). The mutations in position 6 (Ile instead
of Leu) and 30 (Thr instead of Met) are conservative since the
biochemical nature of the amino acids did not change with
respect to the consensus sequences. The mutation in residue 77 is
identical to the one observed in pediatric isolates (Fc30) (35). All
these residues are highly solvent-exposed, and neither the MHC-
II binding site nor the TCR binding surfaces were affected by the
mutations, according to the elucidated structure (Figure 1B).
On the other hand, sei showed the same sequence as the
consensus in the two variants of the gene previously described.
SAgs Inhibit Monocyte Proliferation
Four SAgs of the egc operon were cloned in pET-26b, successfully
expressed in transformed E. coli BL21 and purified (SP Figure 1).
In order to study the effect of SAgs on innate immune cells
and in the absence of T cells, a human monocyte cell line
(THP-1) was cultured for 48 h in the presence of the four
recombinant SAgs, and proliferation by [3H]-thymidine was
evaluated. Since sen and seu are not always present with the
egc operon, they were not included in this study. All SAgs
assayed caused lower proliferation rates in relation to control
(untreated cells), although different potencies in their effects
were observed. Figure 2 shows a representative result for 48 h
culture of SAg with 0.2 × 106 cells/well where inhibition
of proliferation was observed at as low as 0.1µg/ml for
SEG and SEI and at 10µg/ml for SEM and SEO. Similar
results were obtained for different cell densities (0.2–1.0 ×
106 cells/well).
All SAgs Induce Monocyte Death
We further investigated if SAgs were only responsible for
inhibition of proliferation or if they were also causing cell death.
At first, we observed DNA conformation and SAgs presence in
THP-1 cells by immunofluorescence assay. THP-1 cells charged
with SAgs in their cytoplasm presented nuclear fragmentation,
TABLE 1 | Distribution of SAgs genes in clinically isolated Staphylococcus aureus strains.
Gene
Strain sea seb sec sed see seh sej ser tsst-1 seg sei sei 2 sem sen seo seu
40900 – – + – – – + – – + + – + + + +
41026 – – + – – – – – – + + – + + + +
41192 – – – – – – – – – – – – – + – –
41226 – – + – – – – – + + + – + + + +
41395 – – – – – – – – – + – + + + + +
41399 – – + – – – – – – + + – + + + +
41524 – – – – – – – – – – – – – + – +
41598 – – + – – – – – – – – – – – – –
41627 – + – + – – – – – – – – – + – –
41668 – – + – – – + – – + – – + + + +
41674 – + + – – – – – – + + – + + – +
41759 – – – – – – – – – – – – – + – –
41762 – – – – – – – – – – – – – + – –
% 0 15 54 8 0 0 15 0 8 54 38 8 54 92 46 62
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FIGURE 1 | Amino acid alignment and structure of SEG variants. (A) SEG sequence labeled as consensus has been reported in four strains (N315, Q8RR77, Mu50,
and FRI572) (18, 64, 71). Group A includes strains 40900, 41026, 41226, and 41399. Group B includes strains 41395, 41668, and 41664. Fc30 is used as reference
for pediatric isolates as reported by (45). Identical residues are shown in red. Arrows show sequence sites containing mutations. Sites where a unique sequence is
mutated are shown in yellow, and mutated amino acids in two sequences are shown in white. (B) Overall structure of SEG (pdb 1XXG). Mutations are colored in blue,
MHC-II binding site in yellow, and TCR binding site in green.
indicating cell death. Untreated cells were used as a biological
control (control 1) and SAgs-treated cells incubated with normal
murine sera were used to confirm assay specificity (control 2)
(Figure 3A). In addition, an increment in cellular complexity
was observed by flow cytometry (Figure 3B). This phenomenon
was observed for all egc SAgs, suggesting intracellular events
that could be related to the cell death described above.
Moreover, when THP-1 cells were cultured in the presence
of 10µg/ml of SAgs for 48 h, all toxins showed an increased
percentage of PI-positive THP-1 cells, indicating cell death
induction (Figure 3C).
We observed that SEGwas the toxin inducingmore changes in
cellular complexity and an increase in cell death by PI. Moreover,
SEM induced the lowest effects in both evaluated situations.
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FIGURE 2 | SAgs inhibit proliferation of THP-1 cells. THP-1 cells were
incubated with Sags, and proliferation by [3H]-thymidine was evaluated at
48 h. Results are expressed as the percentage of proliferation related to
untreated conditions. Data are expressed as the mean ± SEM of at least three
independent experiments. Asterisks represent statistical significance with
respect to untreated cells: ***p < 0.001, ****p < 0.0001.
PI-positive cells are usually considered as necrotic cells, but
primary necrotic and post-apoptotic secondary necrotic cells
could not be discriminated by this method (72). To clarify
this point, we performed Annexin V/7AAD and dual acridine
orange/ethidium bromide fluorescent staining. When THP-1
cells were cultured in the presence of 10µg/ml of SAgs for 48 h,
all toxins increased the percentage of 7AAD positive THP-1
cells (Figure 4A). All SAgs, but SEM, increased the proportion
of cells labeled with Annexin-V (Figure 4B); however, only
SEI interestingly showed a low percentage of early apoptosis
(Figure 4C).
Furthermore, THP-1 cells treated with SAgs followed by
AO/EtBr staining showed a viability reduction of the monocytic
cells treated with the four SAgs (Figures 5A,B). SEI and SEO
showed the highest increment in apoptotic cell death, compared
with SEG and SEM. In contrast, although all SAgs showed an
increase of cells undergoing necrosis; only SEO increase was
significantly higher compared to control. In correspondence with
that, only SEO increased the level of LDH measured in THP-1
supernatants (Figure 5C).
Thus, we corroborated the induction of cell death generated
by these toxins, causing the depletion of effector cells from the
innate immune response bymultiplemechanisms.While the four
toxins induced late apoptosis at 48 h, we observed induction of
early apoptosis by SEI and necrosis increment by SEO.
SAgs Induce a Pro-inflammatory Cytokine
Profile in Monocytes
When supernatants of THP-1 cells cultured in the presence of
SAgs for 48 h were analyzed, we observed a significantly higher
production of cytokines IL-6, IL-12, and TNF-α (Figure 6). These
interleukins propitiate a highly inflammatory environment,
proper to eradicate an intracellular bacterium, while S. aureus
spends most of the time as an extracellular pathogen. On the
contrary, no trace of IL-17A, IFN-γ, or IL-10 was detected
FIGURE 3 | SAgs of the egc operon induced monocytic cell death. (A) After
48 h of incubation with SAgs, THP-1 cells were labeled with fluorescent
antibodies and observed under the microscope; DNA is shown in blue and
SAgs in green. In the first column, images in bright field are shown. The upper
panel shows the control condition with untreated cells. In the middle and lower
panels, monocytes treated with SAgs are shown. In the middle panel, control
2, cells were incubated with a normal mouse serum and then stained with
fluorescent antibodies. In all cases, representative images are shown. (B)
Cellular complexity was determined as an increment of cells in the upper
quadrants of FSC vs. SCC dot plot. THP-1 cell complexity was assessed by
flow cytometry after 48 h of incubation with SAgs. For this purpose, THP-1
cells were gated for singlets, and then the monocytic population was
evaluated by FSC and SCC. Values are expressed as percentage of cells in the
upper quadrants. Representative dot plots are shown on the right. (C) THP-1
cells were incubated with SAgs for 48 h and then stained with FDA/PI. In this
case, after singlet cell and monocytic population selection, the percentage of
PI+ cells was measured for every SAg treatment and its basal. Values are
expressed as the percentage of PI+ cells. Representative histograms are
shown on the right. Data are expressed as the mean ± SEM of at least three
independent experiments. Asterisks represent statistical significance with
respect to untreated cells: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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FIGURE 4 | SAgs induced cell death in THP-1 cells by different mechanisms. After 48 h of incubation with SAgs, THP-1 cells were incubated with Annexin V-PE and
7AAD, and the proportion of positive cells was measured before the singlet and monocytic population gating strategy. Values are expressed as the percentages of
7AAD positive cells (A), Annexin V positive cells (B), and Annexin V-positive/7AAD-negative cells (C). Data are expressed as the mean ± SEM of at least three
independent experiments. Asterisks represent statistical significance with respect to untreated cells: **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, non-significant
difference.
(results not shown). Evidently, there is cell activation at the same
time that death process starts to occur.
Interestingly, SEG was the weakest to induce IL-6 production
by THP-1 cells and in all cases showed a decline in cytokine levels
at the highest concentrations (Figure 6).
SAgs Induce Cell Death in Monocytes
Differentiated Into Macrophages
Since macrophages are the major phagocytic cells, THP-1 cells
were differentiated into them by treatment with PMA and then
incubated with SAgs to evaluate their effects.
To evaluate cell death, AO/EtBr assay was performed
(Figures 7A,B). THP-1 cells treated with PMA and incubated
with SAgs for 48 h followed by AO/EtBr staining showed a
reduction on the macrophage-like cell viability. Although the
effect on viability is less marked than with THP-1 cells, all
SAgs augmented the percentage of death by apoptosis, with
SEG being the one that induced the lowest increment. In
contrast, even though all SAgs showed an increase in the
percentage of cells undergoing necrosis, that increment was
significantly higher than the control for SEG, SEM, and SEO, but
not for SEI.
All SAgs of the egc operon induced macrophage production
of IL-6 in a concentration-dependent manner, but SEG and SEI
increased the production of this cytokine at lower doses than
SEM and SEO (Figure 7C). Production of IL-12, IFN-γ, or IL-10
was not detected in any case (results not shown).
Monocyte Damage Is Mediated by SAgs
Interaction With DR1 HLA Class II
Molecules
With the aim of verifying whether the SAg effect on monocytes
could be extended to streptococcal superantigen A (SSA), we
pre-incubated THP-1 cells with SSA and found 60% inhibition
of cell proliferation, similar to that obtained with staphylococcal
SAgs (Figure 8). SSA inhibition of proliferation, as well as
SEG and SEI inhibition, was abrogated by incubation with
F(ab)’2 portion of specific polyclonal antibodies for each
SAg (Figure 8).
Since the interaction of SEG and SEI with DR1-HLA, an
isoform of the HLA class II molecule expressed on the THP-
1 cell surface, is well-documented (35, 45, 65), we analyzed
if SAgs damage to monocytic cells could be attributed to the
binding of DR1. In addition, we also analyzed if the SAg
SSA from S. pyogenes displayed a similar effect on monocytic
cells. We had previously observed that SSA caused inhibition
of proliferation similar to the SAgs of the egc operon (results
not shown). SAgs and recombinant DR1 were pre-incubated at
equimolar concentration for 60min at 37◦C, and the effects of
the complex on THP-1 cells were analyzed by proliferation assay.
The results in Figure 8 show that the pre-incubation of SAgs with
the DR1 molecule inhibits the SAg effects on monocytes when
proliferation is measured. These results strongly suggest that the
SAg binding site with DR1 is required for THP-1 cell damage
mediated by these toxins.
SAgs Induce the Upregulation of Different
Cluster Differentiation Markers Through
Molecules Other Than DR1
All evaluated SAgs at 1µg/ml had the capacity to induce
the increase of CD14, CD40, and CD86 markers on THP-1
cells. CD14-positive cells were increased between 5 and 15%
by SAgs with respect to control (untreated cells) (Figure 9A).
CD14 ultimately activates NF-κB, and its overexpression shows
a more mature stage of monocytes, which are shown slightly
activated here.
CD40 signaling plays an important role in the proliferation
and differentiation of B cells, and its upregulation implies
monocytic activation. An increment of at least 100% of CD40-
positive monocytes was observed after incubation with SAgs,
with respect to control (Figure 9C).
In concordance, the co-stimulatory molecule CD86 is
upregulated up to 50% by SAg incubation (Figure 9E). CD86
induces lymphocyte activation, thereby triggering cellular
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FIGURE 5 | SAgs induced cell death in THP-1 cells by apoptosis and some
necrosis. Acridine orange-ethidium bromide staining of monocytic cells (THP-1)
under different treatment conditions (representative images). (A) Control
THP-1 cells (left panel) and SAgs treatment (right panel) are shown. Asterisks
indicate early apoptosis cells, regular arrows show late apoptosis cells, and
wide arrows show necrosis. (B) Viability and type of death percentage of
THP-1 cells treated with SAgs or untreated (control). The result is based on the
analysis of live and apoptotic/necrotic cells following acridine orange-ethidium
bromide (AO/EtBr) staining. (C) Analysis of LDH assay of THP-1 cells treated
with SAgs or left untreated. *p < 0.05, ***p < 0.001, ****p < 0.0001.
immune response, although it has also been implicated in
immune regulation.
The upregulation of CD14 and CD40 did not disappear when
SAgs were pre-incubated with DR1 before incubation with THP-
1 cells (Figures 9B,D), suggesting that there are other possible
molecular targets for SAgs on the surface of monocytes, which
trigger the augmented expression of these molecules. For CD86,
the upregulation caused by SAgs is partially prevented when pre-
incubated with DR1 (Figure 9F), also indicating more than one
target implicated in this molecule regulation.
Phagocytosis Is Not Induced by Incubation
With SAgs
When pre-incubated with SEG, SEI, or SSA, THP-1 cells did
not change the ratio of phagocytosis of heat-killed bacteria
(SP Figure 2). This result shows that, although an activated
profile can be seen, the effector profile of these cells is not
well-developed, as could be suggested by previous results.
Gp130, a Glycoprotein Expressed on the
Monocytic Cells, Binds Non-classical SAgs
The molecule gp130, a glycoprotein expressed on monocyte
cell surface (73), as described as a possible target of classical
SAgs having an Asp227, a residue which is also involved in
the binding to the β chain of the DR1 (48). Considering that
SEI, a non-classical SAg, possesses an Asp in the homologous
position (Asp209) (45), we analyzed SEI interaction with gp130
by SPR. One-fold dilutions of SEI (40–2.5µM) were passed
through gp130 immobilized on a CM5 chip surface displaying
a specific interaction (Figure 10). The kinetic 1:1 interaction
model displayed unambiguous results exhibiting a KD of 1.7
× 10−5 M, with a very slow association rate (kon) of (8.3 ±
0.2) × 102 (Ms)−1 and a moderate dissociation rate (koff) of
(13.8 ± 0.3) × 10−3 s−1. Even though the calculations of the
rates were univocal, the model did not display a good fit to
the experimental values. When a second model, assuming a
cooperativemodel or a 1:2 interaction was applied, a similar value
of KD was obtained. Considering that the interaction between
DR1 and SEI is mediated by Zn, we also performed SPR in the
presence of EDTA to sequester the cation (45), and the binding
was not avoided (data not shown), suggesting that the SEI-gp130
interaction is independent of Zn.
Since the interaction between gp130 and SAg was only
described for SEA and it was suggested that this interaction
would depend on the presence of Asp227, we analyzed if the
egc SAg SEG, which lacks Asp227 and binds to the DR1 α chain
(35), also interacts with gp130. Surprisingly, SEG showed a higher
affinity for gp130 than SEI, displaying a faster kon and a slower
koff than SEI (Table 2, Figure 10). SEM and SEO also displayed
a specific interaction with gp130 (Figure 10) with KD values
similar to that calculated for the SEG-gp130 interaction. The
affinity between SEG, SEM, or SEO with gp130 did not show
significant differences (Table 2).
DISCUSSION
In the current study, we determined that the egc operon is
frequently found in the 13 analyzed strains, in concordance with
an extensive prospective study in Colombia (74). In contrast to
this study, our results in the analyzed strains demonstrated that
sen (previously sek) was more frequent than the operon itself. All
the analyzed strains carrying the egc operon are also bearers of
seu, increasing the virulence of the S. aureus strains (18, 49). This
phenomenon could be explained in terms of the increment of
vβ TCR isoforms interacting with different SAgs, which allows
a major activation of the T cell population. Former publications
described seven types of egc operon. Here we found a new form
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FIGURE 6 | All SAgs induced production of pro-inflammatory cytokines by THP-1 cells. Cytokines were measured in supernatants of treated cells; values are
expressed in pg/ml. IL-6 (A), IL-12 (B), and TNF-α (C) production is shown. No production of IL-10, IL-17, or IFN-γ was detected in any case. Data are expressed as
the mean ± SEM of at least three independent experiments. Asterisks represent statistical significance with respect to untreated cells: **p < 0.01, ****p < 0.0001.
of the operon, named egc 8, which is characterized by the absence
of the seo gene.
Although sed and sej can be encoded in the same plasmid (71),
we found them separately in the genomic DNA of two different
strains. These results are not surprising as many types of sags are
encoded in mobile genomic elements which allow the integration
into chromosomal DNA.
In general, staphylococcal sag genes are well-conserved and
display minor allelic variations. However, we have previously
described new allelic variants between seg and sei genes
in Argentinean autochthonous strains (35). Pediatric isolates
revealed mutations that were expressed as up to 10 changes
in the SEI amino acid sequence and two in the SEG amino
acid sequence. In this study, we observed that adult isolates
displayed lower variability in the DNA sequence which resulted
in non-variations detected for the sei nucleotide sequences
compared with the consensus and four mutations distributed
in pairs in SEG predictive mature proteins. These results could
suggest that sag genes obtained from strains infecting adults
and ambulatory patients displayed much lower variability than
strains isolated from pediatric patients. The mutations detected
in the SEG predictive mature protein altered residues located
outside the MHC-II binding site or the TCR contact surface.
These mutations appear as residues highly exposed to the solvent,
located in mobile loops in the quaternary structure of the protein
and very accessible to antibody recognition, suggesting a target to
avoid the neutralization in future infections (9, 35, 75).
The SAg effects on T cells are very well-documented; however,
the actions of these toxins on cells of the innate immunity at the
early stages of infection when T cells are absent have not been
deeply evaluated. Previously, our group described the interaction
between SEG and mouse dendritic cells (mDCs) (59) using an
in vivo and in vitro model. SAgs activate mDCs, increasing the
phagocytosis process and inhibiting its maturation. In addition,
we demonstrated that SAgs enter in the DC, avoiding the
classical pathway of antigen degradation, and are finally exposed
as intact molecules on the DC surface, a situation that would
allow the interaction with MHC-II and TCR when the DCs
encounter the T cells in the lymph nodes (59). However, as
far as we know, SAgs impact on other isolated innate immune
cells, such as human monocytes and macrophages, had not been
studied yet.
Considering that the egc operon is the most frequent
SAg cluster detected in autochthonous strains of S. aureus,
we evaluated the activity of its SAgs over monocytes and
macrophages using the THP-1 cell line as a model of human
monocytes. A previous work reported that the interaction
between human monocytes enriched from PBMCs and the
staphylococcal enterotoxin B (SEB) induced monocyte apoptosis
and secretion of IFN-γ (56). However, the presence of T cells,
source of IFN-γ (76), in those preparations cannot be discarded.
In the present work, SEG, SEI, SEM, and SEO inhibit monocyte
basal proliferation in a dose-dependent manner, promoting cell
death mostly by an apoptotic process with less incidence of
necrotic death, exhibiting a proinflammatory profile of cytokines
characterized by high levels of TNF-α, IL-6, and IL-12, but
no IFN-γ. Only SEI induced early apoptosis, suggesting some
differences among SAgs kinetic behavior at cell death level.
The absence of CD4+ T cells in the culture could explain the
lack of IFN-γ production in THP-1 cells. The secretion of this
cytokine and the mechanism of cell death in monocytes seem
to depend, in part, on the presence of CD4+ T cells (76).
The released cytokines are in agreement with an M1 profile,
with a high inflammatory environment that could promote a
Th1 response that it is not the most appropriate for the S.
aureus eradication. In concordance with these results, no IL-
10 was detected, favoring a proinflammatory cytokine storm
which is essential for TSS unleashing. It was reported that THP-1
monocyte cells could secrete IL-17A under certain stimuli (77).
Nevertheless, not one of the egc SAgs induced IL-17A secretion
under our experimental conditions.
Monocytic- and macrophagic-like cells showed the
same profile of proliferation inhibition and production of
proinflammatory cytokines, but only the macrophagic-like
cells treated with SEM and SEO had the capacity to induce
the production of nitrites at higher concentrations (100µg/ml,
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FIGURE 7 | PMA THP-1 differentiated cells are more sensitive than THP-1
cells to the SAg effect. Acridine orange-ethidium bromide staining of
PMA-treated THP-1 cells under different treatment conditions (representative
images). (A) Control THP-1/PMA cells (left panel) and SAgs treatment (right
panel) are shown. Asterisks indicate early apoptosis cells, regular arrows show
late apoptosis cells, and wide arrows show necrosis. (B) Viability and type of
death percentage of THP-1/PMA cells treated with SAgs or untreated (control).
The result is based on the analysis of live and apoptotic/necrotic cells following
acridine orange-ethidium bromide (AO/EtBr) staining. (C) Cytokines were
measured in supernatants by ELISA; production of IL-6 is shown. Values are
expressed in pg/ml. Data are expressed as the mean ± SEM of at least three
independent experiments. Asterisks represent statistical significance with
respect to untreated cells: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
data not shown), a characteristic of classical macrophage
activation, which would accompany the previously mentioned
inflammatory response.
In order to determine if the effects observed on monocytes
were restricted to the action of egc SAgs or could be
extended to enterotoxins of other bacterial species, we also
evaluated the effect of streptococcal superantigen A (SSA)
on innate immune system cells. Although staphylococcal and
streptococcal SAgs display structural and behavioral similarities,
FIGURE 8 | Inhibition of cell proliferation is prevented when SAgs are
preincubated with HLA-DR1 or F(ab)’2. THP-1 cells were incubated with SAgs
alone or with SAgs preincubated with DR1 or F(ab)’2 α-Sags, and proliferation
was evaluated by [3H]-thymidine at 48 h. Results are expressed as the
percentage of proliferation related to untreated condition (basal) for each SAg.
In this experiment and the following, only the most studied egc SAgs, SEG,
and SEI and streptococcal SSA were assessed. Data are expressed as the
mean ± SEM of at least three independent experiments. Asterisks represent
statistical significance with respect to the untreated cells in each treatment:
****p < 0.0001, ns, non-significant difference. Hashes represent statistical
significance with respect to cells treated only with SAgs in each treatment:
####p < 0.0001.
staphylococcal and streptococcal TSS differ in their clinical
signs, origin of infection, and prognosis (66, 78). In order
to elucidate if egc SAgs and SSA shared comparable effects
on innate immune system cells, we studied both types of
toxins. egc SAgs and SSA inhibited monocytic cell proliferation
and induced the same monocyte phenotype: SEG, SEI, and
SSA induced the overexpression of cluster differentiation
molecules 14, 40, and 86. Despite this fact, no increase
in phagocytosis was observed in either case, showing an
inefficient activation of monocytic cells by these SAgs. In a
previous work, we reported that the treatment of dendritic
cells with SEG, in the absence of T cells, did not disturb the
viability of these cells, increased phagocytosis, and inhibited cell
maturation (59).
Monocytic THP-1 cells express high levels of MHC-II
molecule DR1, a natural ligand of SAgs (79). The interaction
of DR1 with SEG, SEI, and SSA is very well documented (35,
45, 65, 80). Consequently, we investigated if the effect of SAgs
on monocytes was mediated by the SAg binding site with DR1.
Pre-incubation of SAgs with DR1 avoided the effect of SAgs on
monocytic cells. These results could be in concordance with those
published by Ferreira Duarte et al. (60) where staphylococcal
enterotoxin A (SEA) inhibits mouse neutrophil migration, which
is reverted prior to incubation of the cells with an antibody to the
MHC-II molecule.
The induction of the expression of CD14 and CD40 after
SAg treatment seemed to be independent of the interaction
site with the DR1, suggesting that other sites of the SAgs or
other molecules on the monocyte surface could be involved in
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FIGURE 9 | SAgs affect the expression of cluster differentiation (CD) markers. THP-1 monocytic cells were treated for 48 h with SAgs and then were incubated with
antibodies to CD14 (A), CD40 (C), and CD86 (E). Moreover, using SEI as a representative SAg, we performed the same assay with pre-incubation of SEI with DR1 in
order to evaluate its effect on CD expression (B,D,F). Specific interaction of SEI and tSEI was evaluated by SPR. Cytometry results were expressed as the percentage
of positive cells for each marker. Data are expressed as the mean ± SEM of at least three independent experiments. Asterisks represent statistical significance with
respect to the untreated cells in each treatment: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, non-significant difference. Hashes represent statistical
significance with respect to treated cells with SAgs alone: #p < 0.05, ns, non-significant difference.
FIGURE 10 | Specific interaction of SAgs with gp130. Sensorgrams of gp130–SAgs interaction are shown. Specific interaction between gp130 and SEG (A), SEI (B),
SEM (C), and SEO (D) are shown. The adjustments of experimental data to an interaction model 1:1 are shown as insets.
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−1 K D (M)
SEI (8.3 ± 0.2) × 102 (13.8 ± 0.3) × 10−3 1.7 × 10−5
SEG (11.9 ± 0.1) × 102 (6.2 ± 0.1) × 10−3 5.2 × 10−6
SEM (19.9 ± 0.1) × 102 (9.9 ± 0.4) × 10−3 5.0 × 10−6
SEO (22.7 ± 0.6) × 102 (12.6 ± 0.2) × 10−3 5.6 × 10−6
this process. New targets of SAgs on the APC were recently
described (42, 81, 82). The interaction between classical SAgs
and CD28, and with B7.2 (CD86), the cognate ligand of the
CD28, was already described by others (40–44, 47) and could
promote a full activation of T cells. The interaction between
SAgs and B7.2 would be carried out through a conserved
domain among classical and non-classical SAgs. However, the
interactions between these new targets and non-classical SAgs
have not been studied yet. In our study, we observed that
monocytic-like cells treatment with non-classical SAgs induces
an overexpression of CD86, which is partially abrogated when
SAgs are pre-incubated with the DR1 molecule (Figure 9E).
Since macrophages interact with Th1 cells in the periphery, the
overexpression of CD86 could promote a strong activation of the
Th1 cells, conducting to the depletion of these cells as happens
in the lymph node. CD38 was also postulated by Zilber et al.
(82) as another SAg ligand on the monocyte surface and could
be considered as a possible candidate to cooperate with DR1
and mediate monocytic activation and subsequent death induced
by these toxins. Gregory et al. (81) postulated CD1a as a co-
stimulatory molecule on monocytes, which could contribute to
T cell activation by SAgs.
Only one study reported that a classical staphylococcal
superantigen, SEA, could bind to gp130, a signal transductor
of IL-6, involving the MHC-II interaction site (48). SEA binds
to MHC-II with high affinity, compromising the residues which
interact with Zn, promoting a long half-life complex with the
beta chain of the DR1 molecule. We previously reported that
SEI binds to the β chain of the DR1-MHC-II molecule and
the processed peptide in a Zn-dependent manner (45). Since
gp130 is expressed on the THP-1 cell surface (73), we evaluated
if SEI, a non-classical egc SAg, interacts with this protein by
SPR. Our results demonstrated that SEI specifically binds to
gp130 with moderate affinity and by one order of magnitude
lower than the value already reported by SEI-DR1 (KD 10−6
M). In addition, we observed that the treatment with EDTA,
a chelating agent of bivalent cations like Zn, did not abrogate
the interaction. We also demonstrated that all egc operon non-
classical SAgs have specific interaction with gp130, showing
a similar kinetic behavior (Figure 10). The physiological role
of these interactions could be explained considering that SAgs
block gp130, preventing IL-6 stimuli and the activation of STAT-
3 pathway, which is needed for the expression of IL-30 in
monocytes (73). Since it has been suggested that IL-30 could be
involved in the sepsis-control-modulating cytokines secreted by
NKT cells (83), inhibition of the synthesis of IL-30 would suit the
spread of bacteria. Nevertheless, more studies must be conducted
to determine the biological meaning of this interaction.
Considering that neither SEG and SEI nor SSA showed
significant differences when human monocytes were treated with
them, we could suggest that this first step of infection, which is
essential for bacterial dissemination and the subsequent disease
prognosis, does not explain the discrepancy of progression to the
TSST observed among toxins belonging to different species (66).
Nevertheless, it is clear that TSS involves other components of
the pathogens which are not evaluated in the present work.
As general conclusions of this work, we propose that
SAgs inhibit monocytic/macrophagic effector cells, promoting
a partial immunosuppression state of the host in the first
stages of the infection, which would favor bacterial spread.
Despite that these toxins increase the expression of the
differentiation clusters evaluated, which suggest cell activation,
they do not stimulate phagocytosis, and as a consequence the
viability of the bacteria would not be affected. Furthermore,
the high level of proinflammatory cytokines released due to
SAgs stimulation could induce a type I acquired immune
response. Even if SAgs promote cell death in a high percentage
of the monocytic/macrophagic population, the fraction that
still remains alive could be maintained primed with SAgs.
As a consequence, when Th1 cells contact the SAg-primed
macrophages, they would suffer a process of apoptosis or energy,
enhancing the immunosuppressive status of the host.
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